Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
At The Market Offering |
Common Stock |
Common Stock
At The Market Offering
|
Additional Paid-in Capital |
Additional Paid-in Capital
At The Market Offering
|
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Beginning balance at Dec. 31, 2020 |
$ 462,339
|
|
$ 8
|
|
$ 1,586,616
|
|
$ 296
|
$ (1,124,581)
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
|
83,372,000
|
|
|
|
|
|
Issuance of common stock, net of commissions and offering costs, value |
1,749
|
$ 2,382
|
|
|
1,749
|
$ 2,382
|
|
|
Issuance of common stock, net of commissions and offering costs, shares |
|
|
|
146,000
|
|
|
|
|
RSU settlements, net of shares withheld |
(1,231)
|
|
|
|
(1,231)
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
449,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
108,000
|
|
|
|
|
|
Stock-based compensation expense |
12,268
|
|
|
|
12,268
|
|
|
|
Net income (loss) |
(78,335)
|
|
|
|
|
|
|
(78,335)
|
Unrealized gain (loss) on available-for-sale securities |
(135)
|
|
|
|
|
|
(135)
|
|
Ending balance at Mar. 31, 2021 |
399,037
|
|
$ 8
|
|
1,601,784
|
|
161
|
(1,202,916)
|
Ending balance (in shares) at Mar. 31, 2021 |
|
|
84,075,000
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
462,339
|
|
$ 8
|
|
1,586,616
|
|
296
|
(1,124,581)
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
|
83,372,000
|
|
|
|
|
|
Net income (loss) |
(246,792)
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(272)
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
310,141
|
|
$ 9
|
|
1,681,481
|
|
24
|
(1,371,373)
|
Ending balance (in shares) at Sep. 30, 2021 |
|
|
88,387,000
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
399,037
|
|
$ 8
|
|
1,601,784
|
|
161
|
(1,202,916)
|
Beginning balance (in shares) at Mar. 31, 2021 |
|
|
84,075,000
|
|
|
|
|
|
RSU settlements, net of shares withheld |
(13)
|
|
|
|
(13)
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
423,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards |
2,599
|
|
|
|
2,599
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
256,000
|
|
|
|
|
|
Stock-based compensation expense |
13,807
|
|
|
|
13,807
|
|
|
|
Net income (loss) |
(83,793)
|
|
|
|
|
|
|
(83,793)
|
Unrealized gain (loss) on available-for-sale securities |
(99)
|
|
|
|
|
|
(99)
|
|
Ending balance at Jun. 30, 2021 |
331,538
|
|
$ 8
|
|
1,618,177
|
|
62
|
(1,286,709)
|
Ending balance (in shares) at Jun. 30, 2021 |
|
|
84,754,000
|
|
|
|
|
|
Issuance of common stock, net of commissions and offering costs, value |
48,701
|
|
$ 1
|
|
48,700
|
|
|
|
Issuance of common stock, net of commissions and offering costs, shares |
|
|
3,259,000
|
|
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
306,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards |
842
|
|
|
|
842
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
68,000
|
|
|
|
|
|
Stock-based compensation expense |
13,762
|
|
|
|
13,762
|
|
|
|
Net income (loss) |
(84,664)
|
|
|
|
|
|
|
(84,664)
|
Unrealized gain (loss) on available-for-sale securities |
(38)
|
|
|
|
|
|
(38)
|
|
Ending balance at Sep. 30, 2021 |
310,141
|
|
$ 9
|
|
1,681,481
|
|
24
|
(1,371,373)
|
Ending balance (in shares) at Sep. 30, 2021 |
|
|
88,387,000
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
279,614
|
|
$ 9
|
|
1,744,695
|
|
(368)
|
(1,464,722)
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
91,671,000
|
|
|
|
|
|
Issuance of common stock, net of commissions and offering costs, value |
|
$ 20,516
|
|
|
|
$ 20,516
|
|
|
Issuance of common stock, net of commissions and offering costs, shares |
|
|
|
1,320,000
|
|
|
|
|
RSU settlements, net of shares withheld |
(616)
|
|
|
|
(616)
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
405,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards |
96
|
|
|
|
96
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
10,000
|
|
|
|
|
|
Stock-based compensation expense |
14,335
|
|
|
|
14,335
|
|
|
|
Net income (loss) |
(88,105)
|
|
|
|
|
|
|
(88,105)
|
Unrealized gain (loss) on available-for-sale securities |
(1,524)
|
|
|
|
|
|
(1,524)
|
|
Ending balance at Mar. 31, 2022 |
224,316
|
|
$ 9
|
|
1,779,026
|
|
(1,892)
|
(1,552,827)
|
Ending balance (in shares) at Mar. 31, 2022 |
|
|
93,406,000
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
279,614
|
|
$ 9
|
|
1,744,695
|
|
(368)
|
(1,464,722)
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
91,671,000
|
|
|
|
|
|
Net income (loss) |
(153,730)
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities |
(2,591)
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
187,113
|
|
$ 9
|
|
1,808,515
|
|
(2,959)
|
(1,618,452)
|
Ending balance (in shares) at Sep. 30, 2022 |
|
|
94,879,000
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
224,316
|
|
$ 9
|
|
1,779,026
|
|
(1,892)
|
(1,552,827)
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
|
93,406,000
|
|
|
|
|
|
RSU settlements, net of shares withheld |
(3)
|
|
|
|
(3)
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
647,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards |
1,309
|
|
|
|
1,309
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
303,000
|
|
|
|
|
|
Stock-based compensation expense |
14,117
|
|
|
|
14,117
|
|
|
|
Net income (loss) |
18,466
|
|
|
|
|
|
|
18,466
|
Unrealized gain (loss) on available-for-sale securities |
(726)
|
|
|
|
|
|
(726)
|
|
Ending balance at Jun. 30, 2022 |
257,479
|
|
$ 9
|
|
1,794,449
|
|
(2,618)
|
(1,534,361)
|
Ending balance (in shares) at Jun. 30, 2022 |
|
|
94,356,000
|
|
|
|
|
|
RSU settlements, net of shares withheld |
(4)
|
|
|
|
(4)
|
|
|
|
RSU settlements, net of shares withheld, shares |
|
|
517,000
|
|
|
|
|
|
Issuance of common stock pursuant to employee stock awards |
47
|
|
|
|
47
|
|
|
|
Issuance of common stock pursuant to employee stock awards, shares |
|
|
6,000
|
|
|
|
|
|
Stock-based compensation expense |
14,023
|
|
|
|
14,023
|
|
|
|
Net income (loss) |
(84,091)
|
|
|
|
|
|
|
(84,091)
|
Unrealized gain (loss) on available-for-sale securities |
(341)
|
|
|
|
|
|
(341)
|
|
Ending balance at Sep. 30, 2022 |
$ 187,113
|
|
$ 9
|
|
$ 1,808,515
|
|
$ (2,959)
|
$ (1,618,452)
|
Ending balance (in shares) at Sep. 30, 2022 |
|
|
94,879,000
|
|
|
|
|
|